Insulet (PODD) Tops Q3 EPS by 34c; offers guidance
Tweet
Share
E-mail
Get Alerts PODD Hot Sheet
Price: $150.58 +1.65%
Revenue Growth %: +18.1%
Financial Fact:
Other expense, net: -5.37M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Revenue Growth %: +18.1%
Financial Fact:
Other expense, net: -5.37M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q3 EPS of $0.74, $0.34 better than the analyst estimate of $0.40. Revenue for the quarter came in at $432.7 million versus the consensus estimate of $414.32 million.
For the year ending December 31, 2023, the Company is raising its expected revenue growth to a range of 26% to 27% (previously 22% to 25%).
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
- BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18
- Mama's Creations, Inc. (MAMA) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
